{"id":10357,"date":"2015-12-10T08:19:00","date_gmt":"2015-12-10T08:19:00","guid":{"rendered":"http:\/\/drupal.test\/projects\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/"},"modified":"2022-07-26T16:42:49","modified_gmt":"2022-07-26T20:42:49","slug":"mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/","title":{"rendered":"Mesure et mod\u00e9lisation de l&rsquo;\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l&rsquo;\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer"},"content":{"rendered":"<p>Les cancers du sein et des ovaires sont des causes importantes de maladie et de d\u00e9c\u00e8s chez les Nord-Am\u00e9ricaines. Les tumeurs de ces cancers peuvent subir diff\u00e9rentes mutations, ce qui engendre des cellules qui peuvent ne pas r\u00e9agir de la m\u00eame mani\u00e8re au traitement. Les d\u00e9cisions de traitement tiennent toutefois rarement compte de cette diversit\u00e9 g\u00e9n\u00e9tique dans les tumeurs, m\u00eame si on croit que cette diversit\u00e9 contribue \u00e0 la r\u00e9sistance aux m\u00e9dicaments et \u00e0 la progression de la maladie. Les nouvelles technologies de s\u00e9quen\u00e7age ont donn\u00e9 un aper\u00e7u de la nature de l\u2019\u00e9volution des tumeurs, mais on ne sait pas encore clairement comment les processus \u00e9volutifs contribuent au cancer.<\/p>\n<p>M. Sohrab Shah et son \u00e9quipe utilisent les donn\u00e9es de s\u00e9quen\u00e7age obtenues \u00e0 partir d\u2019\u00e9chantillons des cancers du sein et des ovaires pour cr\u00e9er un logiciel qui am\u00e9liorera la compr\u00e9hension de l&rsquo;\u00e9volution tumorale et aidera \u00e0 pr\u00e9voir les r\u00e9sultats cliniques.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les cancers du sein et des ovaires sont des causes importantes de maladie et de d\u00e9c\u00e8s chez les Nord-Am\u00e9ricaines. Les tumeurs de ces cancers peuvent subir diff\u00e9rentes mutations, ce qui engendre des cellules qui peuvent ne pas r\u00e9agir de la m\u00eame mani\u00e8re au traitement. Les d\u00e9cisions de traitement tiennent toutefois rarement compte de cette diversit\u00e9 [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[94],"genome-competitions":[226],"project-sector":[],"genome_centres":[105],"class_list":["post-10357","project","type-project","status-publish","hentry","project-categories-leading-edge-technologies-fr","genome-competitions-concours-2012-en-bio-informatique-et-en-genematique","genome_centres-genome-british-columbia-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mesure et mod\u00e9lisation de l&#039;\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l&#039;\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mesure et mod\u00e9lisation de l&#039;\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l&#039;\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Les cancers du sein et des ovaires sont des causes importantes de maladie et de d\u00e9c\u00e8s chez les Nord-Am\u00e9ricaines. Les tumeurs de ces cancers peuvent subir diff\u00e9rentes mutations, ce qui engendre des cellules qui peuvent ne pas r\u00e9agir de la m\u00eame mani\u00e8re au traitement. Les d\u00e9cisions de traitement tiennent toutefois rarement compte de cette diversit\u00e9 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T20:42:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\\\/\",\"name\":\"Mesure et mod\u00e9lisation de l'\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l'\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2015-12-10T08:19:00+00:00\",\"dateModified\":\"2022-07-26T20:42:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mesure et mod\u00e9lisation de l&rsquo;\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l&rsquo;\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mesure et mod\u00e9lisation de l'\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l'\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/","og_locale":"fr_FR","og_type":"article","og_title":"Mesure et mod\u00e9lisation de l'\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l'\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer - GenomeCanada","og_description":"Les cancers du sein et des ovaires sont des causes importantes de maladie et de d\u00e9c\u00e8s chez les Nord-Am\u00e9ricaines. Les tumeurs de ces cancers peuvent subir diff\u00e9rentes mutations, ce qui engendre des cellules qui peuvent ne pas r\u00e9agir de la m\u00eame mani\u00e8re au traitement. Les d\u00e9cisions de traitement tiennent toutefois rarement compte de cette diversit\u00e9 [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T20:42:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/","url":"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/","name":"Mesure et mod\u00e9lisation de l'\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l'\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2015-12-10T08:19:00+00:00","dateModified":"2022-07-26T20:42:49+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/mesure-et-modelisation-de-levolution-tumorale-partir-des-donnees-de-sequencage-de-nouvelle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Mesure et mod\u00e9lisation de l&rsquo;\u00e9volution tumorale \u00e0 partir des donn\u00e9es de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration pour permettre l&rsquo;\u00e9tude clinique de la diversit\u00e9 clonale chez les patients atteints de cancer"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10357\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10357"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10357"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10357"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10357"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}